Sartorius Stedim Biotech (SSB) has entered a global collaboration agreement with Lonza, expanding its product array of cell culture media for biopharma manufacturing processes.   SSB will assume global sales and marketing of Lonza’s media and buffers used in the manufacture of protein-based therapeutics and vaccines, and Lonza will continue provide development, manufacture and logistics operations for these products. The cell culture media, sold in liquid or powder form, will be converted to pac...